Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamera J Corte

Showing results (61-70 of 154) with videos related to

Pageof 16
Sort By:
Respiratory Medicine|July 29, 2024
The 1-min sit-to-stand test as a screening tool to assess exercise-induced oxygen desaturation in normoxemic people with interstitial lung diseaseSimone Visser, Chloe Lawler, Caitlin C Fermoyle, et al.
The Lancet. Respiratory Medicine|October 4, 2019
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trialToby M Maher, Tamera J Corte, Aryeh Fischer, et al.
Respirology (Carlton, Vic.)|March 12, 2026
Characterising Patient Pathways Prior to the Diagnosis of Interstitial Lung DiseaseCaitlin C Fermoyle, John Townend, Vidya Navaratnam, et al.
ERJ Open Research|March 17, 2022
Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysisQiang Zheng, Ingrid A Cox, Julie A Campbell, et al.
Thorax|December 5, 2020
Top 10 research priorities for people living with pulmonary fibrosis, their caregivers, healthcare professionals and researchersGabriella Tikellis, Allison Tong, Joanna Y T Lee, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|October 26, 2022
The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness studyIngrid A Cox, Barbara de Graaff, Hasnat Ahmed, et al.
Respirology (Carlton, Vic.)|January 4, 2012
Pulmonary function vascular index predicts prognosis in idiopathic interstitial pneumoniaTamera J Corte, Stephen J Wort, Peter S MacDonald, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 17, 2021
The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from AustraliaIngrid A Cox, Barbara de Graaff, Hasnat Ahmed, et al.
Journal of Internal Medicine|August 3, 2023
Occupational interstitial lung diseasesPaolo Spagnolo, Christopher J Ryerson, Sabina Guler, et al.
Respiration; International Review of Thoracic Diseases|April 19, 2021
Baseline Characteristics and Survival of an Australian Interstitial Pneumonia with Autoimmune Features CohortAdelle S Jee, Matthew J S Parker, Jane F Bleasel, et al.
Pageof 16

Showing results (61-70 of 154) with videos related to

Sort By:
Pageof 16
Respiratory Medicine|July 29, 2024
The 1-min sit-to-stand test as a screening tool to assess exercise-induced oxygen desaturation in normoxemic people with interstitial lung diseaseSimone Visser, Chloe Lawler, Caitlin C Fermoyle, et al.
The Lancet. Respiratory Medicine|October 4, 2019
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trialToby M Maher, Tamera J Corte, Aryeh Fischer, et al.
Respirology (Carlton, Vic.)|March 12, 2026
Characterising Patient Pathways Prior to the Diagnosis of Interstitial Lung DiseaseCaitlin C Fermoyle, John Townend, Vidya Navaratnam, et al.
ERJ Open Research|March 17, 2022
Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysisQiang Zheng, Ingrid A Cox, Julie A Campbell, et al.
Thorax|December 5, 2020
Top 10 research priorities for people living with pulmonary fibrosis, their caregivers, healthcare professionals and researchersGabriella Tikellis, Allison Tong, Joanna Y T Lee, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|October 26, 2022
The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness studyIngrid A Cox, Barbara de Graaff, Hasnat Ahmed, et al.
Respirology (Carlton, Vic.)|January 4, 2012
Pulmonary function vascular index predicts prognosis in idiopathic interstitial pneumoniaTamera J Corte, Stephen J Wort, Peter S MacDonald, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 17, 2021
The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from AustraliaIngrid A Cox, Barbara de Graaff, Hasnat Ahmed, et al.
Journal of Internal Medicine|August 3, 2023
Occupational interstitial lung diseasesPaolo Spagnolo, Christopher J Ryerson, Sabina Guler, et al.
Respiration; International Review of Thoracic Diseases|April 19, 2021
Baseline Characteristics and Survival of an Australian Interstitial Pneumonia with Autoimmune Features CohortAdelle S Jee, Matthew J S Parker, Jane F Bleasel, et al.
Pageof 16